Protagenic Therapeutics, Inc.\new Operating Expenses
Protagenic Therapeutics, Inc.\new (PTIX) reported Operating Expenses of $961.25 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new operating expenses for the quarter ending 2026-06-30 was $961.25K, a 20.45% decline year-over-year.
- Protagenic Therapeutics, Inc.\new operating expenses for the quarter ending 2026-03-31 was $120.33K, a 91.69% decline year-over-year.
- Protagenic Therapeutics, Inc.\new operating expenses for the quarter ending 2025-12-31 was $925.10K, a 130.47% increase year-over-year.
- Protagenic Therapeutics, Inc.\new operating expenses for the quarter ending 2025-09-30 was $1.11M, a 213.43% increase year-over-year.
- Protagenic Therapeutics, Inc.\new operating expenses for fiscal 2026 was $4.50M, a 73.65% increase from fiscal 2025.
- Protagenic Therapeutics, Inc.\new operating expenses for fiscal 2025 was $2.59M.
- Protagenic Therapeutics, Inc.\new operating expenses for fiscal 2024 was $5.70M, a 25.93% increase from fiscal 2023.
- Protagenic Therapeutics, Inc.\new operating expenses for fiscal 2023 was $4.53M, a 27.24% increase from fiscal 2022.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $961.25K 10-Q · filed 2026-08-19 | $1.08M derived: sum of 2 quarters · filed 2026-08-19 | $2.01M derived: sum of 3 quarters · filed 2026-08-19 | $3.12M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2026-03-31 | $120.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | $1.05M derived: sum of 2 quarters · filed 2026-08-14 | $2.16M derived: sum of 3 quarters · filed 2026-08-14 | $4.50M 10-K · filed 2026-08-14 | |
| 2025-12-31 | $925.10K 10-Q · filed 2026-03-09 | $2.04M derived: sum of 2 quarters · filed 2026-03-09 | $4.38M 10-Q · filed 2026-03-09 | $4.70M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-09-30 | $1.11M 10-Q · filed 2025-11-26 | $3.46M 10-Q · filed 2025-11-26 | $3.77M derived: sum of 3 quarters · filed 2026-08-19 | $4.17M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-06-30 | $1.21M 10-Q · filed 2026-08-19 | $2.34M 10-QT · filed 2025-09-10 | $2.66M derived: sum of 2 quarters · filed 2026-08-19 | $3.06M derived: sum of 3 quarters · filed 2026-08-19 | $3.41M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $1.45M 10-Q · filed 2025-05-13 | $1.85M derived: sum of 2 quarters · filed 2026-03-09 | $2.20M derived: sum of 3 quarters · filed 2026-03-09 | $2.59M 10-K · filed 2026-08-14 | |
| 2024-12-31 | $401.40K 10-Q · filed 2026-03-09 | $756.77K derived: sum of 2 quarters · filed 2026-03-09 | $1.08M 10-Q · filed 2026-03-09 | $5.70M 10-K · filed 2025-03-31 | |
| 2024-09-30 | $355.37K 10-Q · filed 2025-11-26 | $652.07K 10-Q · filed 2024-11-14 | $677.21K 10-Q · filed 2025-11-26 | $4.06M 10-Q · filed 2024-11-14 | $3.63M derived: sum of 4 quarters · filed 2025-11-26 |
| 2024-06-30 | $321.83K 10-QT · filed 2025-09-10 | $1.67M 10-Q · filed 2024-08-14 | $3.41M 10-Q · filed 2024-08-14 | $3.27M derived: sum of 3 quarters · filed 2025-09-10 | $4.70M derived: sum of 4 quarters · filed 2025-09-10 |
| 2024-03-31 | $1.74M 10-Q · filed 2025-05-13 | $2.95M derived: sum of 2 quarters · filed 2025-05-13 | $4.38M derived: sum of 3 quarters · filed 2025-05-13 | $5.53M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.64M derived: sum of 2 quarters · filed 2025-03-31 | $3.79M derived: sum of 3 quarters · filed 2025-03-31 | $4.53M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.43M 10-Q · filed 2024-11-14 | $2.58M derived: sum of 2 quarters · filed 2024-11-14 | $3.31M 10-Q · filed 2024-11-14 | $3.97M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $1.14M 10-Q · filed 2024-08-14 | $1.88M 10-Q · filed 2024-08-14 | $2.54M derived: sum of 3 quarters · filed 2024-08-14 | $3.46M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $739.29K 10-Q · filed 2024-05-15 | $1.40M derived: sum of 2 quarters · filed 2024-05-15 | $2.32M derived: sum of 3 quarters · filed 2024-05-15 | $2.96M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $655.78K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | $1.58M derived: sum of 2 quarters · filed 2024-05-14 | $2.22M derived: sum of 3 quarters · filed 2024-05-14 | $3.56M 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | $924.06K 10-Q · filed 2023-11-14 | $1.56M derived: sum of 2 quarters · filed 2023-11-14 | $2.90M 10-Q · filed 2023-11-14 | $3.76M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $636.67K 10-Q · filed 2023-08-14 | $1.98M 10-Q · filed 2023-08-14 | $2.84M derived: sum of 3 quarters · filed 2023-08-14 | $3.60M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $1.34M 10-Q · filed 2023-05-15 | $2.20M derived: sum of 2 quarters · filed 2023-05-15 | $2.97M derived: sum of 3 quarters · filed 2023-05-15 | $4.28M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $861.22K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.63M derived: sum of 2 quarters · filed 2023-03-31 | $2.93M derived: sum of 3 quarters · filed 2023-03-31 | $4.14M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $764.17K 10-Q · filed 2022-11-14 | $2.07M derived: sum of 2 quarters · filed 2022-11-14 | $3.28M 10-Q · filed 2022-11-14 | $3.82M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $1.31M 10-Q · filed 2022-08-11 | $2.52M 10-Q · filed 2022-08-11 | $3.05M derived: sum of 3 quarters · filed 2022-08-11 | $4.14M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $1.21M 10-Q · filed 2022-05-13 | $1.74M derived: sum of 2 quarters · filed 2022-05-13 | $2.84M derived: sum of 3 quarters · filed 2022-05-13 | $3.32M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $536.88K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | $1.63M derived: sum of 2 quarters · filed 2022-04-07 | $2.12M derived: sum of 3 quarters · filed 2022-04-07 | $2.55M 10-K · filed 2022-04-07 | |
| 2020-09-30 | $1.09M 10-Q · filed 2021-11-15 | $1.58M derived: sum of 2 quarters · filed 2021-11-15 | $2.01M 10-Q · filed 2021-11-15 | $2.84M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $488.94K 10-Q · filed 2021-08-16 | $1.01M 10-Q · filed 2021-08-16 | $1.75M derived: sum of 3 quarters · filed 2021-08-16 | $1.94M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $520.74K 10-Q · filed 2021-05-17 | $1.26M derived: sum of 2 quarters · filed 2021-05-17 | $1.45M derived: sum of 3 quarters · filed 2021-05-17 | $1.95M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $737.23K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $926.85K derived: sum of 2 quarters · filed 2021-03-25 | $1.43M derived: sum of 3 quarters · filed 2021-03-25 | $2.09M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $189.62K 10-Q · filed 2020-11-16 | $694.89K derived: sum of 2 quarters · filed 2020-11-16 | $1.35M 10-Q · filed 2020-11-16 | $1.87M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $505.26K 10-Q · filed 2020-08-14 | $1.16M 10-Q · filed 2020-08-14 | $1.68M derived: sum of 3 quarters · filed 2020-08-14 | $2.18M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $654.01K 10-Q · filed 2020-06-18 | $1.18M derived: sum of 2 quarters · filed 2020-06-18 | $1.68M derived: sum of 3 quarters · filed 2020-06-18 | $2.36M derived: sum of 4 quarters · filed 2020-06-18 | |
| 2018-12-31 | $524.25K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $1.02M derived: sum of 2 quarters · filed 2020-04-29 | $1.71M derived: sum of 3 quarters · filed 2020-04-29 | $2.31M 10-K · filed 2020-04-29 | |
| 2018-09-30 | $498.07K 10-Q · filed 2019-11-14 | $1.18M derived: sum of 2 quarters · filed 2019-11-14 | $1.79M 10-Q · filed 2019-11-14 | $2.50M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $685.13K 10-Q · filed 2019-08-14 | $1.29M 10-Q · filed 2019-08-14 | $2.00M derived: sum of 3 quarters · filed 2019-08-14 | $2.53M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $606.68K 10-Q · filed 2019-05-16 | $1.32M derived: sum of 2 quarters · filed 2019-05-16 | $1.84M derived: sum of 3 quarters · filed 2019-05-16 | $2.31M derived: sum of 4 quarters · filed 2019-05-16 | |
| 2017-12-31 | $708.78K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $1.24M derived: sum of 2 quarters · filed 2019-03-29 | $1.71M derived: sum of 3 quarters · filed 2019-03-29 | $2.37M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $527.03K 10-Q · filed 2018-11-08 | $998.62K derived: sum of 2 quarters · filed 2018-11-08 | $1.66M 10-Q · filed 2018-11-08 | $2.21M derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | $471.59K 10-Q · filed 2018-08-14 | $1.13M 10-Q · filed 2018-08-14 | $1.69M derived: sum of 3 quarters · filed 2018-08-14 | $2.14M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $657.92K 10-Q · filed 2018-05-15 | $1.21M derived: sum of 2 quarters · filed 2018-05-15 | $1.67M derived: sum of 3 quarters · filed 2018-05-15 | $2.17M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $556.28K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.01M derived: sum of 2 quarters · filed 2018-04-02 | $1.51M derived: sum of 3 quarters · filed 2018-04-02 | $2.23M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $454.83K 10-Q · filed 2017-11-13 | $951.48K derived: sum of 2 quarters · filed 2017-11-13 | $1.68M 10-Q · filed 2017-11-13 | $1.83M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $496.66K 10-Q · filed 2017-08-08 | $1.22M 10-Q · filed 2017-08-08 | $1.37M derived: sum of 3 quarters · filed 2017-08-08 | $1.73M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $725.74K 10-Q · filed 2017-05-15 | $876.74K derived: sum of 2 quarters · filed 2017-05-15 | $1.24M derived: sum of 3 quarters · filed 2017-05-15 | $1.34M derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $151.00K 10-Q · filed 2016-03-11 | $281.00K 10-Q · filed 2016-03-11 | $612.80K derived: sum of 3 quarters · filed 2016-11-17 | $1.03M 10-K/A · filed 2017-05-08 | |
| 2015-09-30 | $360.84K 10-Q · filed 2016-11-17 | $130.00K 10-Q · filed 2015-11-13 | $461.80K derived: sum of 2 quarters · filed 2016-11-17 | $511.72K 10-Q · filed 2016-11-17 | $648.72K derived: sum of 4 quarters · filed 2016-11-17 |
| 2015-06-30 | $100.96K 10-Q · filed 2016-08-15 | $150.88K 10-Q · filed 2016-08-15 | $287.88K derived: sum of 3 quarters · filed 2016-08-15 | $491.00K 10-K · filed 2015-09-25 | |
| 2015-03-31 | $49.92K 10-Q · filed 2016-07-25 | $121.00K 10-Q · filed 2015-05-11 | $186.92K derived: sum of 2 quarters · filed 2016-07-25 | $377.00K 10-Q · filed 2015-05-11 | $434.92K derived: sum of 4 quarters · filed 2016-07-25 |
| 2014-12-31 | $137.00K 10-Q · filed 2016-03-11 | $256.00K 10-Q · filed 2016-03-11 | $385.00K derived: sum of 3 quarters · filed 2016-03-11 | $292.10K 8-K/A · filed 2016-07-12 | |
| 2014-09-30 | $118.00K 10-Q · filed 2015-11-13 | $248.00K derived: sum of 2 quarters · filed 2015-11-13 | $646.00K derived: sum of 3 quarters · filed 2015-11-13 | $888.00K derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $528.00K derived: sum of 2 quarters · filed 2015-09-25 | $770.00K derived: sum of 3 quarters · filed 2015-09-25 | $975.00K 10-K · filed 2015-09-25 | |
| 2014-03-31 | $398.00K 10-Q · filed 2015-05-11 | $640.00K derived: sum of 2 quarters · filed 2015-05-11 | $845.00K 10-Q · filed 2015-05-11 | ||
| 2013-12-31 | $242.00K 10-Q · filed 2015-02-06 | $447.00K 10-Q · filed 2015-02-06 | |||
| 2013-09-30 | $206.00K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |